
Protagonist Therapeutics Inc
NASDAQ:PTGX

Relative Value
The Relative Value of one
PTGX
stock under the Base Case scenario is
15.64
USD.
Compared to the current market price of 56.64 USD,
Protagonist Therapeutics Inc
is
Overvalued by 72%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
